Status:
COMPLETED
Evaluation of Robotic Exoskeletons Therapy for Gait Rehabilitation in Patients With Incomplete Spinal Cord Injury.
Lead Sponsor:
Hospital Nacional de Parapléjicos de Toledo
Collaborating Sponsors:
Institut Guttmann
Conditions:
Spinal Cord Injury
Incomplete Spinal Cord Injury
Eligibility:
All Genders
16-70 years
Phase:
NA
Brief Summary
The objective of the study is to assess the efficacy of the Exo-H2 robotic exoskeleton for walking rehabilitation of people with incomplete spinal cord injury.
Detailed Description
The recovery of walking ability is a primary concern of rehabilitation programs for people who have suffered anincomplete spinal cord injury. Robotic therapy arises from the new concepts of neuroplast...
Eligibility Criteria
Inclusion
- Incomplete Spinal Cord Syndrome, ASIA scale C or D
- enough strength in the upper extremities to handle a walker or crutches (triceps brachial muscle balance ≥ 3)
- Age between 16 and 70 y.o.
- Heigth: 1.6-1.9m
- Weigth less than 120Kg
- Stable medical condition between 6 weeks and 18 months since injury.
- Subjects must tolerate standing and be included in walking rehabilitation program in the center.
- Lower limb spasticity should be lower than 3 as measyred by Ashworth scale.
Exclusion
- Cardiovascular diseases.
- Upper limb pathology of any kind.
- irreducible flexo or arthrodesis in lower limb joints, 2 or more osteoporotic fractures in the lower limbs in the last 2 years
- Uncontrolled epilepsy.
- Ulcers sores at the contact points with the exoskeleton.
- Refuse to participate.
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 3 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03477123
Start Date
January 1 2016
End Date
July 3 2020
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Hospital for Paraplegics
Toledo, Spain, 45071